Abstract
BackgroundThe management of systemic inflammatory diseases, such as Rheumatoid arthritis (RA) and Ankylosing spondylitis (AS) has been revolutionized with the introduction of tumor necrosis factor alpha inhibitors (TNF-I). Significant reduction...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have